These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11068791)

  • 1. Vaccine helps thwart herpes in women.
    AIDS Read; 2000 Oct; 10(10):574. PubMed ID: 11068791
    [No Abstract]   [Full Text] [Related]  

  • 2. Vical initiates vaccine trials against HSV-2 and CMV.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(2):255. PubMed ID: 24963522
    [No Abstract]   [Full Text] [Related]  

  • 3. Agenus‘ genital herpes vaccine significantly reduces viral burden in Phase 2.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(8):2141-2. PubMed ID: 25580483
    [No Abstract]   [Full Text] [Related]  

  • 4. Parental acceptance of adolescent vaccines within school-based health centres.
    Short MB; Rupp R; Stanberry LR; Rosenthal SL
    Herpes; 2005 Jun; 12(1):23-7. PubMed ID: 16026641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of prophylactic vaccines for genital and neonatal herpes.
    Jones CA; Cunningham AL
    Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease.
    Jones CA; Cunningham AL
    Herpes; 2004 Apr; 11(1):12-7. PubMed ID: 15115632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice.
    Jazayeri M; Soleimanjahi H; Fotouhi F; Pakravan N
    Comp Immunol Microbiol Infect Dis; 2009 Sep; 32(5):453-61. PubMed ID: 18571235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital herpes vaccine shows limited promise.
    Stephenson J
    JAMA; 2000 Oct; 284(15):1913-4. PubMed ID: 11035871
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
    J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines.
    Stanberry LR
    Herpes; 2004 Aug; 11 Suppl 3():161A-169A. PubMed ID: 15319086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic strategies for herpes vaccination.
    Hartley C
    JAMA; 2000 Feb; 283(6):746; author reply 746-7. PubMed ID: 10683052
    [No Abstract]   [Full Text] [Related]  

  • 12. Could zinc oxide tetrapod nanoparticles be used as an effective immunotherapy against HSV-2?
    Yadavalli T; Shukla D
    Nanomedicine (Lond); 2016 Sep; 11(17):2239-42. PubMed ID: 27527812
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic strategies for herpes vaccination.
    Friedman HM
    JAMA; 2000 Feb; 283(6):746; author reply 746-7. PubMed ID: 10683051
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genital herpes].
    Tewald F; Enders M; Regnath T; Hassler D
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2641-2. PubMed ID: 17190019
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.
    Garnett GP
    J Infect Dis; 2005 Feb; 191 Suppl 1():S97-106. PubMed ID: 15627236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for genital herpes: how, who, and why.
    Wald A
    Curr Clin Top Infect Dis; 2002; 22():166-80. PubMed ID: 12520653
    [No Abstract]   [Full Text] [Related]  

  • 19. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines.
    Schwartz EJ; Blower S
    J Infect Dis; 2005 May; 191(10):1734-46. PubMed ID: 15838802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.